search
Back to results

Determination of In-vivo Plasma AA Appearance From Plant Protein Fibre Products

Primary Purpose

Aging, Undernutrition, Appetite Loss

Status
Completed
Phase
Phase 2
Locations
International
Study Type
Interventional
Intervention
Net peripheral AA appearance following ingestion of 3 selected PPF products compared to whey
Sponsored by
University College Dublin
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Aging focused on measuring Amino Acid, Gut hormones, Older adults, Successful ageing, Plant protein, Fibre

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Community-dwelling, Age 65+ years, not a heavy smoker (≤10/day), BMI 18-30 kg/m2

Exclusion Criteria:

  • Medical condition or medication known to impact appetite or energy intake, consumes more than 14 (female) or 21 (male) units of alcohol per week, inability to come to study centre, self-reported cognitive impairment or diagnosis of clinical depression, heavy smoker (>10/day)

Sites / Locations

  • University college Dublin
  • University of Padua Department of Biomedical Science, Neuromuscular Physiology Laboratory

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Active Comparator

Arm Label

Test meal incorporating the study groups innovative plant protein and fibre (variety 3) product.

Test meal incorporating the study groups innovative plant protein and fibre (variety 5) product.

Test meal incorporating the study groups innovative plant protein and fibre (variety 6) product.

Test meal incorporating the control comparator (whey protein isolates), plus 10g of added pea fibre.

Arm Description

The standardised test meal was prepared in a single dose using Knorr low sodium chicken stock cubes (9g = 1 stock cube), 65.64g of plant protein and fibre variety 3 (3.09g leucine), 28.6g butter, 5.12g cornflour, and 300ml water. The test meal is consumed in a single sitting in the morning following an overnight fast. Blood samples are acquired at baseline and at set intervals over the subsequent 3-hours to examine the net peripheral amino acid appearance.

The standardised test meal was prepared in a single dose using Knorr low sodium chicken stock cubes (9g = 1 stock cube), 67.78g of plant protein and fibre variety 3 (3.09g leucine), 27.79g butter, 4.63g cornflour, and 300ml water. The test meal is consumed in a single sitting in the morning following an overnight fast. Blood samples are acquired at baseline and at set intervals over the subsequent 3-hours to examine the net peripheral amino acid appearance.

The standardised test meal was prepared in a single dose using Knorr low sodium chicken stock cubes (9g = 1 stock cube), 57.66g of plant protein and fibre variety 3 (3.09g leucine), 31.72g butter, 6.62g cornflour, and 300ml water. The test meal is consumed in a single sitting in the morning following an overnight fast. Blood samples are acquired at baseline and at set intervals over the subsequent 3-hours to examine the net peripheral amino acid appearance.

The standardised test meal was prepared in a single dose using Knorr low sodium chicken stock cubes (9g = 1 stock cube), 36.59g of unflavoured Optimum Nutrition gold standard 100% whey protein (3.09g leucine), 33.23g butter, 9.09g cornflour, and 300ml water. The test meal is consumed in a single sitting in the morning following an overnight fast. Blood samples are acquired at baseline and at set intervals over the subsequent 3-hours to examine the net peripheral amino acid appearance.

Outcomes

Primary Outcome Measures

Acute change in amino acid appearance in peripheral blood following a test meal ingestion
Arterialised blood samples will be drawn from antecubital vein and centrifuged at 4˚C for 10 minutes at 4000rpm and frozen at -80˚C until analysed. Samples will be analysed using HPLC methods and expressed in μmol/L.

Secondary Outcome Measures

Acute changes in appetite and desire to eat
Changes in appetite and are assessed at set time points throughout the testing session, matched for timing of biological sample collection. This will be assessed using the validated visual analogue scale (VAS) method. The Visual Analogue Scale is a 100mm scale with anchors on each end describing extreme answers. On the left side of the scale is the extreme negative response and the right side the positive response. Participants mark the line were appropriate between both extremes.
Sensory properties and palatability of the test meal after ingestion
Participants will rate each test meal on their perceived sensory properties and rate different aspects related to its palatability. These are important considerations when developing new products and will be assessed using the validated visual analogue scale (VAS) method. The Visual Analogue Scale is a 100mm scale with anchors on each end describing extreme answers. On the left side of the scale is the extreme negative response and the right side the positive response. Participants mark the line were appropriate between both extremes.

Full Information

First Posted
May 4, 2022
Last Updated
September 23, 2022
Sponsor
University College Dublin
Collaborators
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, University of Padova, Fraunhofer Institute for Interfacial Engineering and Biotechnology
search

1. Study Identification

Unique Protocol Identification Number
NCT05420142
Brief Title
Determination of In-vivo Plasma AA Appearance From Plant Protein Fibre Products
Official Title
Innovative plAnt Protein Fibre and Physical Activity Solutions to Address Poor appEtite and prevenT undernutrITion in oldEr Adults (APPETITE): Determination of In-vivo Plasma AA Appearance From Plant Protein Fibre Products
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
March 14, 2022 (Actual)
Primary Completion Date
May 12, 2022 (Actual)
Study Completion Date
July 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University College Dublin
Collaborators
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, University of Padova, Fraunhofer Institute for Interfacial Engineering and Biotechnology

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to assess the digestibility and efficacy of the study groups previously developed innovative plant-based protein and fibre products.
Detailed Description
Older people are at high risk of undernutrition, which leads to serious adverse health outcomes, but effective preventive strategies are lacking. Effective, new strategies should focus on the etiology of undernutrition and directly address potential causes and mechanisms underpinning undernutrition. Reduced food intake and restricted dietary diversity are direct consequences of poor appetite. Recent studies have shown, that older persons with a poor appetite demonstrate lower intake of protein and dietary fibre, and of several nutrient-rich food groups (e.g. meat, fish, wholegrains, vegetables), after adjustment for energy intake and other potential confounders, but a higher consumption of food groups low in micronutrients (e.g. fats, oils, sweets, and sodas), compared to those with good appetite. Enhancing dietary protein and fibre intake in older Europeans is a key objective because intake of both nutrients is sub- optimal, not only in those with poor appetite. Adequate protein intake prevents excessive decline in muscle mass and function (sarcopenia), a widespread health-issue in older persons, intensified by undernutrition. Adequate dietary fibre intake prevents constipation and impedes the development of many chronic diseases prevalent in older people. Thus, targeting adequate protein and fibre intake may be particularly beneficial in this vulnerable population. A preparatory short-term study will be performed to assess in 10 healthy older adults the net peripheral Amino Acid (AA) appearance following ingestion of 3 selected Plant-based Proteins and Fibre (PPF) products previously developed by the wider study collaborators, compared to the reference of 30 g whey protein. Plasma concentrations of AA from arterialised blood will be measured by ion exchange chromatography in blood samples (1 drawn before and 6 during 3 hours postprandial). This step will allow the research group to compare in-vitro (previous work) and in-vivo digestibility of several PPF mixtures and identify the product with both optimal amino acid composition and sensory properties as well as optimal post-prandial plasma amino acid profile to be used in further studies.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aging, Undernutrition, Appetite Loss, Age-Related Sarcopenia
Keywords
Amino Acid, Gut hormones, Older adults, Successful ageing, Plant protein, Fibre

7. Study Design

Primary Purpose
Basic Science
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
9 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Test meal incorporating the study groups innovative plant protein and fibre (variety 3) product.
Arm Type
Experimental
Arm Description
The standardised test meal was prepared in a single dose using Knorr low sodium chicken stock cubes (9g = 1 stock cube), 65.64g of plant protein and fibre variety 3 (3.09g leucine), 28.6g butter, 5.12g cornflour, and 300ml water. The test meal is consumed in a single sitting in the morning following an overnight fast. Blood samples are acquired at baseline and at set intervals over the subsequent 3-hours to examine the net peripheral amino acid appearance.
Arm Title
Test meal incorporating the study groups innovative plant protein and fibre (variety 5) product.
Arm Type
Experimental
Arm Description
The standardised test meal was prepared in a single dose using Knorr low sodium chicken stock cubes (9g = 1 stock cube), 67.78g of plant protein and fibre variety 3 (3.09g leucine), 27.79g butter, 4.63g cornflour, and 300ml water. The test meal is consumed in a single sitting in the morning following an overnight fast. Blood samples are acquired at baseline and at set intervals over the subsequent 3-hours to examine the net peripheral amino acid appearance.
Arm Title
Test meal incorporating the study groups innovative plant protein and fibre (variety 6) product.
Arm Type
Experimental
Arm Description
The standardised test meal was prepared in a single dose using Knorr low sodium chicken stock cubes (9g = 1 stock cube), 57.66g of plant protein and fibre variety 3 (3.09g leucine), 31.72g butter, 6.62g cornflour, and 300ml water. The test meal is consumed in a single sitting in the morning following an overnight fast. Blood samples are acquired at baseline and at set intervals over the subsequent 3-hours to examine the net peripheral amino acid appearance.
Arm Title
Test meal incorporating the control comparator (whey protein isolates), plus 10g of added pea fibre.
Arm Type
Active Comparator
Arm Description
The standardised test meal was prepared in a single dose using Knorr low sodium chicken stock cubes (9g = 1 stock cube), 36.59g of unflavoured Optimum Nutrition gold standard 100% whey protein (3.09g leucine), 33.23g butter, 9.09g cornflour, and 300ml water. The test meal is consumed in a single sitting in the morning following an overnight fast. Blood samples are acquired at baseline and at set intervals over the subsequent 3-hours to examine the net peripheral amino acid appearance.
Intervention Type
Dietary Supplement
Intervention Name(s)
Net peripheral AA appearance following ingestion of 3 selected PPF products compared to whey
Intervention Description
The intervention will assess the effects of three difference varieties of plant-based protein and fibre supplements on net peripheral amino acid appearance in blood compared to whey protein with matched fibre content as a control arm.
Primary Outcome Measure Information:
Title
Acute change in amino acid appearance in peripheral blood following a test meal ingestion
Description
Arterialised blood samples will be drawn from antecubital vein and centrifuged at 4˚C for 10 minutes at 4000rpm and frozen at -80˚C until analysed. Samples will be analysed using HPLC methods and expressed in μmol/L.
Time Frame
Blood samples will be taken at baseline, and at 30, 60, 90, 120, 150, & 180 minutes following ingestion of test sample
Secondary Outcome Measure Information:
Title
Acute changes in appetite and desire to eat
Description
Changes in appetite and are assessed at set time points throughout the testing session, matched for timing of biological sample collection. This will be assessed using the validated visual analogue scale (VAS) method. The Visual Analogue Scale is a 100mm scale with anchors on each end describing extreme answers. On the left side of the scale is the extreme negative response and the right side the positive response. Participants mark the line were appropriate between both extremes.
Time Frame
baseline, 30, 60, 90, 120, 150, & 180 minutes following ingestion of a sample meal
Title
Sensory properties and palatability of the test meal after ingestion
Description
Participants will rate each test meal on their perceived sensory properties and rate different aspects related to its palatability. These are important considerations when developing new products and will be assessed using the validated visual analogue scale (VAS) method. The Visual Analogue Scale is a 100mm scale with anchors on each end describing extreme answers. On the left side of the scale is the extreme negative response and the right side the positive response. Participants mark the line were appropriate between both extremes.
Time Frame
Immediately following test meal ingestion (single measure)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Community-dwelling, Age 65+ years, not a heavy smoker (≤10/day), BMI 18-30 kg/m2 Exclusion Criteria: Medical condition or medication known to impact appetite or energy intake, consumes more than 14 (female) or 21 (male) units of alcohol per week, inability to come to study centre, self-reported cognitive impairment or diagnosis of clinical depression, heavy smoker (>10/day)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Helen Roche, Prof
Organizational Affiliation
University College Dublin
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Katy Horner, Dr
Organizational Affiliation
University College Dublin
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Dominique Dardevet, Dr
Organizational Affiliation
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE)
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Giuseppe De Vito, Prof
Organizational Affiliation
University of Padua Department of Biomedical Science, Neuromuscular Physiology Laboratory
Official's Role
Principal Investigator
Facility Information:
Facility Name
University college Dublin
City
Dublin
State/Province
Leinster
Country
Ireland
Facility Name
University of Padua Department of Biomedical Science, Neuromuscular Physiology Laboratory
City
Padova
ZIP/Postal Code
35131
Country
Italy

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Determination of In-vivo Plasma AA Appearance From Plant Protein Fibre Products

We'll reach out to this number within 24 hrs